Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium aurotiosulfate, also known as sanocrysin, is an inorganic coordination complex with the formula Na₃[Au(S₂O₃)₂]·2H₂O. It is the trisodium salt of a gold(I) thiosulfate complex and appears as a colorless dihydrate. Historically, it has been used for its medicinal properties, particularly in the treatment of rheumatoid arthritis and other conditions where gold compounds are indicated. The compound is administered via intramuscular injection. Its mechanism of action is not fully elucidated but relates to its classification among organogold compounds; these are thought to exert anti-inflammatory effects possibly through modulation of immune responses or inhibition of lysosomal enzymes[7][2]. Sodium aurotiosulfate has also been investigated for potential use in hydrometallurgy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium aurotiosulfate.